Average Co-Inventor Count = 5.94
ph-index = 12
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Blueprint Medicines Corporation (12 from 60 patents)
2. Lexicon Pharmaceuticals, Inc. (9 from 86 patents)
3. Vertex Pharmaceuticals, Inc. (8 from 1,152 patents)
4. Bristol-myers Squibb Compnay (3 from 3,685 patents)
5. Actinium Pharmaceuticals, Limited (1 from 22 patents)
30 patents:
1. 11827642 - Compositions useful for treating disorders related to KIT
2. 10774070 - 2-(pyridin-3-yl)-pyrimidine derivatives as RET inhibitors
3. 10736975 - Infusion administration of conjugated monoclonal antibodies
4. 10227329 - Compounds useful for treating disorders related to RET
5. 10202365 - 2-(pyridin-3-yl)-pyrimidine derivatives as RET inhibitors
6. 10000496 - Compositions useful for treating disorders related to kit and PDGFR
7. 9994575 - Compositions useful for treating disorders related to kit
8. 9994552 - Compositions useful for treating disorders related to kit
9. 9944651 - Compositions useful for treating disorders related to kit
10. 9884861 - Compositions useful for treating disorders related to kit
11. 9862724 - Pyrazolo[1,5-a]pyrimidine-based compounds, compositions comprising them, and methods of their use
12. 9499522 - Compositions useful for treating disorders related to kit
13. 9403832 - Pyrazolo[1,5-a]pyrimidine-based compounds, compositions comprising them, and methods of their use
14. 9334263 - Compositions useful for treating disorders related to kit
15. 9200002 - Compositions useful for treating disorders related to KIT